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~068-110[ Defibrillation Threshold~ Are Significantly
Increaaed by A Right-Sided Approach to Totally
Tranavenoua lmplantsbla Defibrillator Systems
Placement
P.A. Friedman, S. Grice, R.E. Espinosa, M.S. Stanton. Mayo Clinic,
Rochestec MN, USA
Background: Whether a totally transvenous implanteble cardiovetier defib-
rillator system (lCD) is placed via a left- or right-sided approach depends
on patient and implantor preference, venous access, and the presence of
a pre-existing pacemaker. ,The defibrillation threshold (DFT) is affected by
lead position, which in turn is determined in part by the side of access. We
reviewed our experience to determine whether the side of venous access
affects DFTs.
Methods and Ffesu/ts:Step down to failure DFTswere found in all patients
at the time of ICD implantation. Patients undergoing left-sided implantation
with two-lead systems typically had the proximal defibrillation coil in a high
SVC or left innominate vein position; right-sided implantation necessitated
lower SVC positioning of the proximal coil due to anatomical constraints.
Of 124 transvenous ICDSimplanted, 24 were excluded from analysis: 20
were active can systems, and 4 were placed in patients with pre-existing
epicardial defibrillation leads. Of the remaining 100 patients, 93 had left-
sidsd systems (32 Endotek, 61 Transvene) and 7 had right-sided systems
(all Transvene). Considering only patienta with Transvene lead systems, the
mean DFT for right-sided implantations was significantly higher than for left-
sided systems (21.0 & 5.0 J vs. 15.2 + 6.1 J, p c 0.05). When the analysis
was further restricted to patients with the same type of ICD (7219D) with
Transvene leads, the difference persisted (right-sided [n =6] 21.0 & 5.0 J,
vs. left-sided [n= 48] 15.8 + 6.1 J, p = 0.05).
Conclusion: The right-sided approach to totally transvenous ICD place-
ment using the Transvene lead system results in significantly higher DFTs
than the left-sided approach. This may bedueto anatomic constraints affact-
ing lead position. This should be considered during pm-implant assessment,
and may become more important as newer lower energy devices become
available.
I 1068-111 I EEWiyActivation~Oi,o~ingSho~~e De,iveredin
Humans. Tha Difference Between Transvenous
and ‘Active Can’ iCD Systems
G.P.Walcott, W.-C. Chau, R.E. Ideker, W.M. Smith, V.J. Plumb, G.N. Kay,
A.E. Epstein. Univemity of Alabama at Birmingham, Birmingham, AL, USA
/introduction: In humans, early activation sites (EAS) following defibrillation
shocks delivered from a transvenous (TV) lead with an eleotrcde in the RV
apex and one in the superior vena ceva arise predominantly fmm the LV
apex and anterior LV free wall. This study was designed to determine the
EAS following shocks delivered from a RV electrode to an ‘active can’ (RV-
AC) pectoral electrode. Methods: Four patients, age 60 + S, undergoing
implantation of an AC ICD were studied. A 3&pole catheter was positioned
in the LV so that poles 1–12 were in the antero-basal segment of the LV
free wall (Pos 1), poles 13-24 were at the LV apex (Pos 2) and poles 26-
36 were in the postero-basal segment of the interventricular septum (Pos
3). Elactrograms were recorded using a custom built 144-channel mapping
system. Defibrillation thresholds (D~) were determined using a step-down
technique. Resu/ta: The DFT was 420+60 V. For successful shocks, EAS
were located in Poa 3 for three patients and Pos 2 for one patient. Earliest
measured activation (EMA) occurred 417 + 463 msec after the shook. For
failed shocks, EAS were loostad at Pos 3 for two patients and Pos 2 for
1 patient; simultaneous early sites were measured at Pos 1 and Pos 3 for
one patient. EMA was recorded 215 +64 msec after the shock. Corrc/usion:
Unlike the location of EAS following shocks from a TV lead which were
located in Pos 1 and 2, EAS following shocks delivered from RV-AC are
remrdad in Pos 2 and Pos 3. This and previous work show for the first time
that in humans changes in electrode configuration can change the pattern of
activation following successful and failed defibrillation shocks.
11068-f121 peCtOrallmplentation of Automatic Defibriliatora
(iCD’S) - Generai Anesthesia vs Conacioua
Sedation
A. Bolimann, N.K. Kanuru, D. DeLurgio, P.Waker, A.R. Leon, J. Bumette,
N. Edwards, J.J. Langbarg, Cardiology Division, Emory University At/anta,
GA, USA
Miniaturization of ICD’Shas decreased the duration and morbidity of implan-
tation, making conscious sedation (SED) a reasonable alternative to general
anesthesia (GA) for this procedure. The purpese of the study was to compare
outcomes in pts having pectoral ICD implantation using GA to those treatad
with SED. Forty consecutive pts were studied. Clinical characteristics and
presenting arrhythmias of pts having ICD with GA (n = 22) were comparable
to the pts treated with SED (n = 18). All pta had the ICD placed deep to
the pactoralis muscle and all were amnestic for the procedure. There were
2 complications requiring reoperation, both in the GA group. Although the
duration of surgery was similar (78+21 min VS71 +24 rein, p= ns), thetotsl
procedure duration was longer in the GA group because of the increased
preparation time (156 + 31 min vs 122 + 36 min. p = 0.005). Pts treatad
with SED did not require admission to the Post-Anesthesia Care Unit, vs
an S9 & 34 min stay for pts subjected to GA. There were no differences in
post-operative narcotic use or the length of stay (2.5+ 1.1 VS2.5 + 1.Sdays).
Procedure-related charges were greater in the pts treated with GA ($2754 +
390 W $1472+ 213, p < 0.001).
Conclusion: Pectoral ICD implantation using SED is well tolerated and
results in a shorter, less expensive procedure.
1~[ Re,atiOnOfEpicardiai andTranSmurai
Conduction in Normai Myocardium
A. Bauer, K.D. Freigang, F,Voss, R. Becker, J.C. Senges, J. Brachmann,
W. Schoels. UniverWyof Heidelberg, Germany
Faster conduction in longitudinal (lo) than in transverse (tr) direction of my-
ocardial muscle fibers has bean demonstrated in epicardial muscle layers.
In transmural (tin) direction, muscle fibers are orientated side by side. Thus,
transmural conduction should be similar to transverse and slower than lon-
gitudinal conduction in the epicardium. Furthermore, trensmural conduction,
like transverse conduction, should be similarly less affected by the sodium-
channel blocker propafenone (P) than longitudinal conduction. In 6 normal
dogs, 6 parallel rows of 6 needle electrodes (1 cm in length, 4 bipolar eleo-
tmdes per needle, interelectrcde distance 0.2 cm, distance between needles
1 cm) were insertad into the anterior left ventricular wall, perpendicular to
the left anterior descending artery, that is, along the long axis of epi- and
endocardial fibers and along the short axis of midmyocsrdial fibers. Using
a computerized multiplexer-mapping system, 192 ekxtrograms were simul-
taneously recorded to reconstruct the spread of activation during constant
pacing at a cycle-length of 300 msec before and after application of 2 mglkg
P intravenously. Baseline values (in m/s) for 10,tr and tm conduction veloc-
ity (CV) without drug and relative changes (aCV in m/s) induoed by P are
summarized in the table below (*p <0.0510 vs tr, *P -=0.0510 vs tm, l*tr vs
tin).
CV control acv
Longitudinal 1.5 + 0.2m/s# 0.3 l0.2m/s#
Transversal 1.2 kO.2m/s* 0.2 + 0.2m/s*
Transmural 0.9+ O.lm/s** 0.1 k O.lm/s**
Conclusions: Throughout the ventricular wall, CV is faster 10to the fiber
orientation than tr and tm. These inhomogeneous conduction propertied
could facilitate the development of reentry-arrhythmias. P raducea CV more
markedly in directions longitudinal to the muscle fibera, thereby deoreaaing
these inhomogeneities. This might represent one mechanism of antiarrhyth-
mic drug action, se lmtential prerequisitea for aniaotropic reentry are being
atwlished.
/1068-1141Heart Rate Variability PrecdingSpontsneoua
Ventricular Tachycardia
V. Shusterman, L. Young, B. Aysin, V. Gottipaty, S. Fahrig, K.P. Anderson
for the ESVEM Investigators. University of Pittsburgh, Pittsbugh, PA, USA
Heart rate variability (HRV) reflects autonomic activity and changes at the
onset of ventricular tachyarrhythmias have been reported in small stud-
ies. We addressad the hypothesis that sustainad monomorphic ventricular
techycardia (VT) is preceded by an increaae in sympathetic activity ancVor
by reduced vagal tone as indicated by changes in HRV. Helter ECGS with
spontaneous VT from 49 patients (p) screened for the ESVEM trial in the
absence of antiarrhythmic drugs were studied. Spectral HRV power [very low
